Show simple item record

dc.contributor.authorAlsinnawi, M
dc.contributor.authorLoftus, B
dc.contributor.authorFlynn, R
dc.contributor.authorMcDermott, T
dc.contributor.authorGrainger, R
dc.contributor.authorThornhill, J A
dc.date.accessioned2013-05-17T15:10:51Z
dc.date.available2013-05-17T15:10:51Z
dc.date.issued2012-12
dc.identifier.citationThe incidence and relevance of prostate cancer in radical cystoprostatectomy specimens. 2012, 44 (6):1705-10 Int Urol Nephrolen_GB
dc.identifier.issn1573-2584
dc.identifier.pmid22773166
dc.identifier.doi10.1007/s11255-012-0224-y
dc.identifier.urihttp://hdl.handle.net/10147/292282
dc.description.abstractTo review the incidence, histopathological features and clinical outcomes of patients with incidental prostate cancer (CaP) found in cystoprostatectomy specimens (CP) excised for bladder cancer and to determine whether these prostate cancers could affect the follow-up strategy.
dc.language.isoenen
dc.rightsArchived with thanks to International urology and nephrologyen_GB
dc.subjectPROSTATE CANCER
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshCystectomy
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshIncidental Findings
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshProstatectomy
dc.subject.meshProstatic Neoplasms
dc.subject.meshRetrospective Studies
dc.subject.meshUrinary Bladder Neoplasms
dc.titleThe incidence and relevance of prostate cancer in radical cystoprostatectomy specimens.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Urology, The Adelaide and Meath Hospital Incorporating The National Children's Hospital, Tallaght, Dublin 24, Ireland.en_GB
dc.identifier.journalInternational urology and nephrologyen_GB
dc.description.provinceLeinsteren
html.description.abstractTo review the incidence, histopathological features and clinical outcomes of patients with incidental prostate cancer (CaP) found in cystoprostatectomy specimens (CP) excised for bladder cancer and to determine whether these prostate cancers could affect the follow-up strategy.


This item appears in the following Collection(s)

Show simple item record